- Udyam number
- UDYAM-AP-12-0016887

About Saanso Pharma Private Limited
Data last updated:
Saanso Pharma Private Limited is a private limited company based in Eluru, Andhra Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 10 April 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U01409AP2017PTC105626. Its GSTIN is 37AAGCG7890P1ZM (Andhra Pradesh). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹21 Cr and a paid-up capital of ₹21 Cr. It was formerly known as Genesis I.B.R.C. Private Limited. It is led by directors including Pruthvi Vankineni Krishna (Whole-Time Director) and Siva Bhaskara Paturi Naren.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Eluru, Andhra Pradesh.
As per the financials filed for FY 2025, the company reported a revenue of ₹17.42 Cr, a growth of 26% compared to the previous year. For the same year it recorded a net profit of ₹39.25 Lakh (net margin 2.3%) and EBITDA of ₹1.55 Cr (EBITDA margin 8.9%).
The company has about 12 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹38.21 Cr on record.
Saanso Pharma Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-AP-12-0016887). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website saansopharma.com.
Company details
Recognitions & Rankings of Saanso Pharma
Contact details
Saanso Pharma Private Limited's registered office is in Eluru, Andhra Pradesh. Its website is saansopharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressDoor No 7 – 177 Dwaraka Tirumala Road, Denduluru Village And Mandal, Eluru, Andhra Pradesh, India – 534432
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Saanso Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Saanso Pharma is manufacturing. In detail, this covers manufacture of chemicals and chemical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 20 | Manufacture of chemicals and chemical products |
To see the full business activity and turnover split of Saanso Pharma Private Limited, buy the company report.
Financials of Saanso Pharma Private Limited
FY 2025 filings availableSaanso Pharma Private Limited reported revenue of ₹17.42 Cr (up 26% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 26% in the latest year. EBITDA rose 52% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.55 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹39.25 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.9% | ||||
| Net Profit Margin | 2.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Saanso Pharma Private Limited, buy the company report.
Board of directors of Saanso Pharma Private Limited
Saanso Pharma has 3 current directors and 10 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Siva Bhaskara Paturi Naren | Director | 01 Feb 2023 | 3 Years 9 Months | Current |
| Vamse Krishna Ratnakaram | Director | 22 Feb 2023 | 3 Years 8 Months | Current |
| Pruthvi Vankineni Krishna Also directs: Ram Infratech LLP, Bean Orbit Private Limited, Adithya Commercials (India) Private Limited and 3 more | Whole-Time Director | 01 Feb 2023 | 3 Years 9 Months | Current |
Peer comparison
Saanso Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (manufacture of chemicals and chemical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sharp Biotech Speciality India Private Limited | ₹18.01 Cr (FY 2025) | 15.0% | Panvel, Maharashtra, India | |||
| Kasturchand Fertilisers Private Limited | ₹17.69 Cr (FY 2025) | -31.0% | Nagpur, Maharashtra, India | |||
| Chamundi Agarbathi India Private Limited | ₹17.64 Cr (FY 2025) | -3.0% | Bangalore, Karnataka, India | |||
| Anuj Engineers (I) Private Limited | ₹17.5 Cr (FY 2025) | 157.0% | Navi Mumbai, Maharashtra, India | |||
| Floorcare Technologies Private Limited | ₹17.44 Cr (FY 2024) | 9.0% | Bangalore, Karnataka, India | |||
| Saanso Pharma Private Limitedthis company | ₹17.42 Cr (FY 2025) | ₹39.25 Lakh | 2.3% | 26.0% | Eluru, Andhra Pradesh, India | |
| Hindustan Fertilizer Corporation Limited | ₹17.24 Cr (FY 2025) | -57.0% | New Delhi, Delhi, India | |||
| Sunlarks Industries Private Limited | ₹17.12 Cr (FY 2025) | 24053.0% | Raipur, Chhattisgarh, India | |||
| Teckno Ingenious Solutions Private Limited | ₹17 Cr (FY 2025) | -24.0% | Mumbai, Maharashtra, India | |||
| Seagull Chemicals Private Limited | ₹16.84 Cr (FY 2025) | -28.0% | Thane, Maharashtra, India | |||
| Mass Dyechem Private Limited | ₹16.84 Cr (FY 2025) | -3.0% | Pune, Maharashtra, India |
To see the full peer comparison of Saanso Pharma Private Limited, buy the company report.
Auditor
Saanso Pharma Private Limited is audited by G V & CO for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| G V & CO | FY 2022 | 012875S |
Shareholding
The shareholding of Saanso Pharma Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Saanso Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 05 Dec 2023 | 100837557 | Others | ₹38 Cr | Open | |
| 07 Feb 2022 | 100556758 | Hdfc Bank Limited | ₹20.6 Lakh | Open |
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Saanso Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Saanso Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Saanso Pharma has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 37AAGCG7890P1ZM | Andhra Pradesh | Active | 01 Jul 2017 |
| 36AAGCG7890P1ZO | Telangana | Active | 15 Mar 2022 |
To see the full GST registrations and return filing status of Saanso Pharma Private Limited, buy the company report.
Recent activity
Saanso Pharma Private Limited has 13 board changes on record since 2017: 3 appointments and 10 cessations. The latest: Pruthvi Vankineni Krishna ceased to be Director on 30 Sep 2023.
6 earlier events are in the company report.
Frequently asked questions
Saanso Pharma is an active private limited company based in Eluru, Andhra Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 10 April 2017 (9+ years old) and is registered under CIN U01409AP2017PTC105626.
Saanso Pharma has 3 current directors:
- Pruthvi Vankineni Krishna - Whole-Time Director
- Siva Bhaskara Paturi Naren - Director
- Vamse Krishna Ratnakaram - Director
The latest financial statements of Saanso Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Saanso Pharma is 37AAGCG7890P1ZM, registered in Andhra Pradesh. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 36AAGCG7890P1ZO (Telangana).
The CIN (Corporate Identification Number) of Saanso Pharma is U01409AP2017PTC105626. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Saanso Pharma was incorporated on 10 April 2017, making it 9+ years old. It is registered with the Registrar of Companies, Vijayawada.
The peers of Saanso Pharma by revenue are Sharp Biotech Speciality India Private Limited, Kasturchand Fertilisers Private Limited, Chamundi Agarbathi India Private Limited, Anuj Engineers (I) Private Limited, Floorcare Technologies Private Limited and 5 more, all in the same principal business activity (manufacture of chemicals and chemical products).
Pruthvi Vankineni Krishna ceased to be Director on 30 Sep 2023. Vamse Krishna Ratnakaram ceased to be Additional Director on 29 Sep 2023. Vamse Krishna Ratnakaram was appointed as Director on 22 Feb 2023. Saanso Pharma has 13 board changes on record in total.
Yes, Saanso Pharma is registered as an MSME under Udyam registration (number: UDYAM-AP-12-0016887).
Saanso Pharma can be reached through the website saansopharma.com. Its registered office is in Eluru, Andhra Pradesh, India.
The registered office of Saanso Pharma is at Door No 7 – 177 Dwaraka Tirumala Road, Denduluru Village And Mandal, Eluru, Andhra Pradesh, India – 534432.

